EP3417294
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.2.2017EP published:
1.12.2021EP application number:
17753704.0
EPO information:
European Patent Register
Max expiry date:
13.2.2037
Title in English:
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIBLanguage of the patent:
English
Timeline
Today
14.2.2017EP application
1.12.2021EP Publication
Owner
Name:
Astrazeneca ABAddress:
151 85 Södertälje, SE
Name:
The United States of America, as Represented By the Secretary, Department of Health and Human ServicesAddress:
Office of Technology Transfer National Institutes of Health 6011 Executive Boulevard Suite 325 MSC 7660, Bethesda, MD 20892-7660, US
Inventor
Name:
BARRY, SimonAddress:
Cambridge CB4 0WG, GB
Name:
KENDREW, JaneAddress:
Macclesfield Cheshire SK10 4TG, GB
Name:
HO, TonyAddress:
Gaithersburg, MD 20878, US
Name:
WEDGE, Stephen, RobertAddress:
Granta Park Cambridge CB21 6GH, GB
Name:
IVY,Susan PercyAddress:
Bethesda, MD 20892-7660, US
Name:
KOHN, EliseAddress:
Bethesda, MD 20892-7660, US
Name:
LEE, Jung-MinAddress:
Bethesda, MD 20892-7660, US
Priority
Number:
201662295421 PDate:
15.2.2016Country:
US
Classification
Categories:
C07K 16/28, G01N 33/574, A61K 38/00, A61P 35/00, A61K 31/502, A61K 31/506, A61K 45/06, A61K 48/00, A61P 9/10, A61P 43/00, A61K 39/395